Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444178
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-05-30
Brief Title:
Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban or Aspirin Plus REGN9933 or Aspirin Plus REGN7508 in Healthy Adult Participants
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Organization Data
Organization:
Regeneron Pharmaceuticals
Class:
INDUSTRY
Study ID:
R9933-HV-2424
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Regeneron Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None